492
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Budget impact model of a 5-grass sublingual immunotherapy tablet for the treatment of grass pollen-induced allergic rhinitis

, , , , , & show all
Pages 909-918 | Accepted 09 Jun 2015, Published online: 06 Jul 2015

References

  • Salo PM, Calatroni A, Gergen PJ, et al. Allergy-related outcomes in relation to serum IgE: Results from the National Health and Nutrition Examination Survey 2005–2006. J Allergy Clin Immunol 2011;127:1226-35.e7
  • Wallace DV, Dykewicz MS, Bernstein DI, et al. The diagnosis and management of rhinitis: An updated practice parameter. J Allergy Clin Immunol 2008;122(Suppl 2):S1-84
  • Arbes SJ Jr, Gergen PJ, Elliott L, et al. Prevalences of positive skin test responses to 10 common allergens in the US population: results from the third National Health and Nutrition Examination Survey. J Allergy Clin Immunol 2005;116:377-83
  • Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J 2004;24:758-64
  • Blaiss MS. Allergic rhinitis: direct and indirect costs. Allergy Asthma Proc 2010;31:375-80
  • Hankin CS, Cox L, Bronstone A, et al. Allergy immunotherapy significantly reduces outpatient services use for chronic respiratory conditions in patients with newly-diagnosed allergic rhinitis. Poster presented at the 2014 AAAAI Annual Meeting, San Diego, CA
  • Cruz AA, Popov T, Pawankar R, et al. Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN. Allergy 2007;62(Suppl 84):1-41
  • Casale TB, Dykewicz MS. Clinical implications of the allergic rhinitis-asthma link. Am J Med Sci 2004;327:127-38
  • Burgess JA, Walters EH, Byrnes GB, et al. Childhood allergic rhinitis predicts asthma incidence and persistence to middle age: a longitudinal study. J Allergy Clin Immunol 2007;120:863-9
  • Shaaban R, Zureik M, Soussan D, et al. Rhinitis and onset of asthma: a longitudinal population-based study. Lancet 2008;372:1049-57
  • Hatzler L, Hofmaier S, Papadoulos NG. Allergic airway diseases in childhood marching from epidemiology to novel concepts of prevention. Pediatr Allergy Immunol 2012;23:616-22
  • Bousquet J, Schünemann HJ, Samolinski B, et al. Allergic rhinitis and its impact on asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol 2012;130:1049-62
  • Lamb CE, Ratner PH, Johnson CE, et al. Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective. Curr Med Res Opin 2006;22:1203-10
  • Radulovic S, Calderon MA, Wilson D, et al. Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev 2010;12:CD002893
  • Durham SR, Emminger W, Kapp A, et al. Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet. J Allergy Clin Immunol 2010;125:131-8
  • Durham SR, Emminger W, Kapp A, et al. SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial. J Allergy Clin Immunol 2012;129:717-25
  • Makatsori M, Calderon MA. Sublingual allergen immunotherapy for respiratory allergies: what is new? Expert Rev Clin Immunol 2014;10:1641-7
  • Wilson DR, Torres LI, Durham SR. Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev 2003;2:CD002893
  • Calderon MA, Alves B, Jacobson M, et al. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev 2007;1:CD001936
  • Di Bona D, Plaia A, Scafidi V, et al. Efficacy of sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a systematic review and meta-analysis. J Allergy Clin Immunol 2010;126:558-66
  • Dranitsaris G, Ellis AK. Sublingual or subcutaneous immunotherapy for seasonal allergic rhinitis: an indirect analysis of efficacy, safety and cost. J Eval Clin Pract 2014;20:225-38
  • Durham SR, Walker SM, Varga EM, et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999;341:468-75
  • Abramson MJ, Puy RM, Weiner JM. Allergen immunotherapy for asthma. Cochrane Database Syst Rev 2003;4:CD001186
  • Calamita Z, Saconato H, Pela AB, et al. Efficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane Collaboration method. Allergy 2006;61:1162-72
  • Hankin CS, Cox L. Allergy immunotherapy: what is the evidence for cost saving? Curr Opin Allergy Clin Immunol 2014;14:363-70
  • Meadows A, Kaambwa B, Novielli N, et al. A systematic review and economic evaluation of subcutaneous and sublingual allergen immunotherapy in adults and children with seasonal allergic rhinitis. Health Technol Assess 2013;17:vi, xi-xiv, 1-322
  • Nelson HS. New forms of allergy immunotherapy for rhinitis and asthma. Allergy Asthma Proc 2014;35:2717
  • Hankin CS, Cox L, Lang D, et al. Allergy immunotherapy among Medicaid-enrolled children with allergic rhinitis: patterns of care, resource use, and costs. J Allergy Clin Immunol 2008;121:227-32
  • ORALAIR® (Sweet Vernal, Orchard, Perennial Rye, Timothy, and Kentucky Blue Grass Mixed Pollens Allergen Extract) [Prescribing information] 2014. Greer Laboratories, Lenoir, NC.
  • Sullivan SD, Mauskopf JA, Augustovski F, et al. Budget impact analysis—Principles of good practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force. Value Health 2014;17:5-14
  • U.S. Census Bureau, Population Division. Annual estimates of the resident population by single year of age and sex for the United States: April 1, 2010 to July 1, 2012. Washington, DC: U.S. Census Bureau; 2013. https://www.census.gov/popest/data/datasets.html. Accessed January 31, 2014
  • Bloom B, Cohen RA, Freeman G. Summary health statistics for U.S. children: National Health Interview Survey, 2011. National Center for Health Statistics. Vital Health Stat 2012;10:1–88
  • Schiller JS, Lucas JW, Peregoy JA. Summary health statistics for U.S. adults: National Health Interview Survey, 2011. National Center for Health Statistics. Vital Health Stat 2012;10:1–218
  • Björkstén B, Clayton T, Ellwood P, et al. Worldwide time trends for symptoms of rhinitis and conjunctivitis: phase III of the international study of asthma and allergies in childhood. Pediatr Allergy Immunol 2008;19:110-24
  • Valero A, Chivato T, Justicia JL, et al. Diagnosis and treatment of grass pollen-induced allergic rhinitis in specialized current clinical practice in Spain. Allergy Asthma Proc 2011;32:384-9
  • Natt RS, Karkos PD, Natt DK, et al. Treatment trends in allergic rhinitis and asthma: a British ENT survey. BMC Ear Nose Throat Disord 2011;11:3
  • Pharmacy Benefit Management Institute. Prescription drug benefit cost and plan design report 2013–2014 edition. Plano, TX: Pharmacy Benefit Management Institute, LP; 2013
  • Micromedex® 2.0, (electronic version). Truven Health Analytics, Greenwood Village, Colorado, USA. http://www.micromedexsolutions.com. Accessed February 10, 2014
  • Hankin CS, Cox L, Bronstone A, et al. Allergy immunotherapy: reduced health care costs in adults and children with allergic rhinitis. J Allergy Clin Immunol 2013;131:1084-91

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.